Abstract:Both the magnitude and duration of insulin signaling are important in executing its cellular functions. Insulin-induced degradation of insulin receptor substrate 1 (IRS1) represents a key negative feedback loop that restricts insulin signaling. Moreover, high concentrations of fatty acids (FAs) and glucose involved in the etiology of obesity-associated insulin resistance also contribute to the regulation of IRS1 degradation. The scavenger receptor CD36 binds many lipid ligands, and its contribution to insulin resistance has been extensively studied, but the exact regulation of insulin sensitivity by CD36 is highly controversial. Herein, we found that CD36 knockdown in C2C12 myotubes accelerated insulin-stimulated Akt activation, but the activated signaling was sustained for a much shorter period of time as compared with WT cells, leading to exacerbated insulin-induced insulin resistance. This was likely due to enhanced insulin-induced IRS1 degradation after CD36 knockdown. Overexpression of WTCD36, but not a ubiquitination-defective CD36 mutant, delayed IRS1 degradation. We also found that CD36 functioned through ubiquitination-dependent binding to IRS1 and inhibiting its interaction with cullin 7, a key component of the multisubunit cullin-RING E3 ubiquitin ligase complex. Moreover, dissociation of the Src family kinase Fyn from CD36 by free FAs or Fyn knockdown/inhibition accelerated insulin-induced IRS1 degradation, likely due to disrupted IRS1 interaction with CD36 and thus enhanced binding to cullin 7. In summary, we identified a CD36-dependent FA-sensing pathway that plays an important role in negative feedback regulation of insulin activation and may open up strategies for preventing or managing type 2 diabetes mellitus.

The CUL7 E3 Ubiquitin Ligase Targets Insulin Receptor Substrate 1 for Ubiquitin-Dependent Degradation

The Functions and Properties of Cullin-5, a Potential Therapeutic Target for Cancers.

Dynamic Molecular Architecture and Substrate Recruitment of Cullin3–ring E3 Ligase CRL3KBTBD2

Increased Cul1 Expression Promotes Melanoma Cell Proliferation Through Regulating P27 Expression

Dynamic molecular architecture and substrate recruitment of cullin3–RING E3 ligase CRL3 KBTBD2

SIRT7 deacetylates DDB1 and suppresses the activity of the CRL4 E3 ligase complexes.

Regulation of Insulin Receptor Substrate‐1 Expression Levels by Caveolin‐1

Lack of CUL4B in Adipocytes Promotes PPARγ-Mediated Adipose Tissue Expansion and Insulin Sensitivity.

CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression

Ubiquitination and Degradation of the Hominoid-Specific Oncoprotein TBC1D3 is Mediated by CUL7 E3 Ligase

The functional analysis of Cullin 7 E3 ubiquitin ligases in cancer

mTORC1 signaling requires proteasomal function and the involvement of CUL4-DDB1 ubiquitin E3 ligase.

Insulin receptor substrate 1/2 (IRS1/2) regulates Wnt/β-catenin signaling through blocking autophagic degradation of dishevelled2.

CUL4 E3 ligase regulates the proliferation and apoptosis of lung squamous cell carcinoma and small cell lung carcinoma

Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies

CRL4BRBBP7 Targets HUWE1 for Ubiquitination and Proteasomal Degradation.

SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis

Ubiquitinated CD36 sustains insulin-stimulated Akt activation by stabilizing insulin receptor substrate 1 in myotubes

X-linked Intellectual Disability Gene CUL4B Targets Jab1/CSN5 for Degradation and Regulates Bone Morphogenetic Protein Signaling.

The CUL5 E3 ligase complex negatively regulates central signaling pathways in CD8 + T cells

CRL3s: The BTB-CUL3-RING E3 Ubiquitin Ligases